Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M
Previously Published on Fiercebiotech.com – Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from…
-
-
Breakthroughs in Pancreatic Cell Replacement: ViaCyte Interview
Previously Published on Diabetes Daily ViaCyte Interview By Christine Fallabel – I recently had the opportunity to sit down with Manasi Sinha Jaiman, M.D.,…
-
Stem Cells May Cure T1D
Medical device company Viacyte has developed a device called PEC-Direct that can protect stem cells to be able to live inside…
-
Diabetes Cure News Type 1
Diabetes Cure News! Johnson & Johnson is joining forces with biotech company ViaCyte to speed development of the first stem…
